GEN Exclusives

More »

GEN News Highlights

More »
Jul 12, 2011

Roche and Caliper to Offer Automated Target Enrichment for Next-Generation Sequencing

  • Roche and Caliper Life Sciences entered into a co-marketing agreement for the development and optimization of automated protocols for the NimbleGen SeqCap EZ library solution-based capture method for Caliper’s Sciclone NGS Workstation. The aim is to simplify high-throughput targeted resequencing workflows by developing automated methods for sequencing library preparation and enrichment of target regions, quantification, and quality control.

    “The continued exponential growth of sequencing throughput and the volume of samples to be analyzed has shifted the bottleneck to sample preparation and process control,” points out Frank Pitzer, Ph.D., CEO of Roche NimbleGen. “By combining our solutions with Caliper’s NGS workstation, the bottlenecks are eliminated, creating the capacity to analyze large cohorts and optimize research efforts.”

    Kevin Hrusovsky, president and CEO of Caliper, adds, “Caliper’s Sciclone NGS Workstation significantly accelerates high-throughput sequencing sample preparation and enrichment for numerous sequencing chemistries and workflows. Together Caliper and Roche NimbleGen are developing targeted sequencing applications that enable studies that analyze variants across large populations to detect and better understand the causal agents of disease.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?